Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-12-10

Clinical Trial Update: Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation [NA]

View source ↗

Summary

A clinical trial evaluating post-operative continuous active combination sex steroids to prevent recurrent endometrioma formation has been withdrawn; no results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oklahoma | Conditions: Endometrioma | NA | Status: WITHDRAWN